id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-252703-00ks1j0x	Keddy, Karen H	Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis	2020-10-15		.txt	text/plain	963	64	46	The global pandemic of COVID-19 has led to a prominent public health response, with many countries introducing highly proactive measures for screening and identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 might additionally negatively affect T-cell-mediated immunity, causing lymphopenia, particularly in those with a severe form of the disease, 8 which could reactivate latent tuberculosis or render patients with COVID-19 more susceptible to acquiring a tuberculosis infection. Any symptomatic patient presenting with presumptive COVID-19 from a population at a high risk for tuberculosis, or from a country in which tuberculosis is highly endemic, 4 should have both diseases considered when it comes to submitting specimens for diagnosis, because of the potential reactivation of latent tuberculosis caused by the presence of SARS-CoV-2, or the greater frequency of tuberculosis presenting as community-acquired pneumonia in those populations.	./cache/cord-252703-00ks1j0x.txt	./txt/cord-252703-00ks1j0x.txt